- Home
- PHAT vs MFH Comparison
PHAT vs MFH Comparison
Compare PHAT & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- MFH
- Stock Information
- Founded
- PHAT 2018
- MFH 2011
- Country
- PHAT United States
- MFH United States
- Employees
- PHAT N/A
- MFH N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- PHAT Health Care
- MFH Finance
- Exchange
- PHAT Nasdaq
- MFH Nasdaq
- Market Cap
- PHAT 423.4M
- MFH 382.7M
- IPO Year
- PHAT 2019
- MFH N/A
- Fundamental
- Price
- PHAT $5.12
- MFH $5.67
- Analyst Decision
- PHAT Strong Buy
- MFH
- Analyst Count
- PHAT 4
- MFH 0
- Target Price
- PHAT $23.00
- MFH N/A
- AVG Volume (30 Days)
- PHAT 1.5M
- MFH 61.4K
- Earning Date
- PHAT 03-06-2025
- MFH 04-21-2025
- Dividend Yield
- PHAT N/A
- MFH N/A
- EPS Growth
- PHAT N/A
- MFH N/A
- EPS
- PHAT N/A
- MFH N/A
- Revenue
- PHAT $55,252,000.00
- MFH $716,863.00
- Revenue This Year
- PHAT $202.16
- MFH N/A
- Revenue Next Year
- PHAT $113.86
- MFH N/A
- P/E Ratio
- PHAT N/A
- MFH N/A
- Revenue Growth
- PHAT 8001.47
- MFH 119.50
- 52 Week Low
- PHAT $4.07
- MFH $1.03
- 52 Week High
- PHAT $19.71
- MFH $8.86
- Technical
- Relative Strength Index (RSI)
- PHAT 41.95
- MFH 47.35
- Support Level
- PHAT $6.03
- MFH $5.28
- Resistance Level
- PHAT $6.89
- MFH $6.42
- Average True Range (ATR)
- PHAT 0.58
- MFH 0.64
- MACD
- PHAT 0.05
- MFH 0.04
- Stochastic Oscillator
- PHAT 37.23
- MFH 56.32
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.